Nasdaq
SUPN
Supernus Pharmaceuticals, Inc.
- Health Care
- Listed 2012
- 1 day
- −0.3%
- 1 month
- −2.5%
- 1 year
- +10.2%
$46.76 · Mkt cap $2.72B
At the 6 Aug 2026 close
Nasdaq
Supernus Pharmaceuticals, Inc.
$46.76 · Mkt cap $2.72B
At the 6 Aug 2026 close
Supernus Pharmaceuticals, Inc. trades under the ticker SUPN on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2012. Its market capitalisation is $2.72B. The last closing price was $46.76, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +10.2%, and −2.5% over the past month. Returns are price returns and exclude dividends.
This page exists because SUPN is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.